Cases started on MDR-TB treatment in South Korea
South Korea: Cases started on MDR-TB treatment was 461 in 2024. ▼ Falling
Cases started on MDR-TB treatment in South Korea, 2011–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for cases started on mdr-tb treatment in South Korea is 461, measured in 2024.
The figure is down 15.7% on the previous year and down 46.1% over ten years.
Over the whole period, cases started on mdr-tb treatment in South Korea peaked at 1,212 in 2012 and was at its lowest, 307, in 2011.
That places South Korea 31st out of 193 countries with data for 2024, putting it in the top quarter.
The long-run direction has been consistently falling across the 14 years of available data.
Cases started on MDR-TB treatment in South Korea, year by year
| Year | Value | Change |
|---|---|---|
| 2011 | 307 | — |
| 2012 | 1,212 | +294.8% |
| 2013 | 951 | -21.5% |
| 2014 | 856 | -10.0% |
| 2015 | 956 | +11.7% |
| 2016 | 888 | -7.1% |
| 2017 | 809 | -8.9% |
| 2018 | 794 | -1.9% |
| 2019 | 749 | -5.7% |
| 2020 | 588 | -21.5% |
| 2021 | 654 | +11.2% |
| 2022 | 560 | -14.4% |
| 2023 | 547 | -2.3% |
| 2024 | 461 | -15.7% |
South Korea compared with similar countries
- South Korea's 461 is above the median for high income countries, which is 7, 65.9× the median. (62 countries reporting)
- South Korea's 461 is above the median for East Asia & Pacific, which is 22, 21.0× the median. (31 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in South Korea changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +294.8% | 307 | 1,212 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 835.78 | 307 | 1,212 | 9 |
| 2020s | 562 | 461 | 654 | 5 |
Countries ranked near South Korea
- 28 Belarus 520 compare
- 29 Cote d'Ivoire 465 compare
- 30 Afghanistan 464 compare
- 32 Moldova 460 compare
- 33 Kenya 458 compare
- 34 Tajikistan 421 compare
More health data for South Korea
- Un projection of annual infant deaths, annual growth rate -1.43 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1935 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,072 deaths per 1,000 people (2090)
- Number of infants who die before age 1 69 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0118 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.76 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in South Korea?
- Cases started on mdr-tb treatment in South Korea was 461 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in South Korea?
- The highest recorded value was 1,212 in 2012.
- What is the lowest cases started on mdr-tb treatment recorded in South Korea?
- The lowest recorded value was 307 in 2011.
- How does South Korea rank for cases started on mdr-tb treatment?
- South Korea ranks 31st out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in South Korea?
- Over the last ten years it is down 46.1%. The long-run trend across the full record is falling.
- Where does this South Korea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).